Zevra Therapeutics Inc (ZVRA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 46,642 | 37,890 | 83,229 | 71,064 | 71,608 |
| Depreciation Amortization | -487 | -256 | 59,636 | 60,131 | 60,950 |
| Accounts receivable | 1,150 | 6,890 | -11,977 | -5,610 | -6,969 |
| Other Working Capital | 16,761 | 16,984 | -10,780 | -1,832 | 929 |
| Other Operating Activity | -40,892 | -55,366 | -121,706 | -130,867 | -138,341 |
| Operating Cash Flow | $23,174 | $6,142 | $-1,598 | $-7,114 | $-11,823 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | 93,972 | N/A | N/A | N/A |
| PPE Investments | -252 | 7 | -387 | -277 | -312 |
| Purchase Of Investment | -80,836 | -58,296 | -309,986 | -222,823 | -157,712 |
| Sale Of Investment | 143,222 | N/A | 328,500 | 241,000 | 180,500 |
| Purchase Sale Intangibles | 48,935 | 43,935 | N/A | N/A | 0 |
| Other Investing Activity | 48,935 | 43,935 | 0 | 0 | 0 |
| Investing Cash Flow | $111,069 | $79,618 | $18,127 | $17,900 | $22,476 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -60,092 | -60,092 | -372 | -372 | -372 |
| Common Stock Issued | 10,358 | 9,923 | 12,436 | 9,890 | 3,360 |
| Other Financing Activity | -1,485 | -2,635 | 0 | 0 | 0 |
| Financing Cash Flow | $-51,219 | $-52,804 | $12,064 | $9,518 | $2,988 |
| Exchange Rate Effect | -109 | 233 | 28 | 350 | 286 |
| Beginning Cash Position | 62,406 | 62,406 | 33,785 | 33,785 | 33,785 |
| End Cash Position | 145,321 | 95,595 | 62,406 | 54,439 | 47,712 |
| Net Cash Flow | $82,915 | $33,189 | $28,621 | $20,654 | $13,927 |
| Free Cash Flow | |||||
| Operating Cash Flow | 23,174 | 6,142 | -1,598 | -7,114 | -11,823 |
| Capital Expenditure | -252 | -35 | -835 | -866 | -312 |
| Free Cash Flow | 22,922 | 6,107 | -2,433 | -7,980 | -12,135 |